{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:00:44Z","timestamp":1793473244433,"version":"4.5.0"},"reference-count":29,"publisher":"American Association of Avian Pathologists (AAAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avian Diseases"],"published-print":{"date-parts":[[2021,9,13]]},"abstract":"<jats:p>To produce more-stable, live attenuated vaccines for infectious laryngotracheitis virus (ILTV), deletion of genes related to virulence has been extensively pursued. Although its function remains unknown, the open reading frame C (ORF C) is among the genes potentially associated with viral virulence that is nonessential for replication in vitro. Earlier results indicated that the ILT virus with deletion of the ORF C gene (B\u0394ORFC) was suitable and safe for eye drop administration but was not sufficiently attenuated for in ovo administration. The objective of this study was to evaluate the safety and protection efficacy of a cell line\u2013adapted, gene-deleted strain (B\u0394ORFC) of ILTV when administered in ovo and\/or spray (SP) by itself, or in combination with the recombinant HVT-LT (rHVT-LT) vaccine. Results indicated that vaccination with the B\u0394ORFC strain, either by itself or in combination with an rHVT-LT vaccine, did not affect hatchability, and only marginal signs of respiratory distress were recorded for groups of chickens that received the B\u0394ORFC strain via SP. The replication and seroconversion induced by the B\u0394ORFC strain after in ovo and SP administration was very limited, whereas the replication of the rHVT-LT vaccine was delayed when combined with the B\u0394ORFC strain in ovo. Compared to rHVT-LT or B\u0394ORFC when administered alone, dual vaccination with rHVT-LT + B\u0394ORFC was more effective in mitigating clinical signs of the disease and reducing challenge virus load in the trachea. To our knowledge, this study provides the first proof of concept that ILTV strains can be sufficiently attenuated for early vaccination in ovo or at hatch; also, this study documented the benefits of using a dual (recombinant and live attenuated) hatchery vaccination strategy for ILTV.<\/jats:p>","DOI":"10.1637\/aviandiseases-d-20-00050","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T05:30:40Z","timestamp":1631079040000},"page":"500-507","source":"Crossref","is-referenced-by-count":3,"title":["A Cell Line Adapted Infectious Laryngotracheitis Virus Strain (B\u0394ORFC) for in ovo and Hatchery Spray Vaccination Alone or in Combination with a Recombinant HVT-LT Vaccine"],"prefix":"10.1637","volume":"65","author":[{"given":"Daniel","family":"Maekawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylva M.","family":"Riblet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Whang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maricarmen","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1212","reference":[{"key":"29","doi-asserted-by":"crossref","unstructured":"V Palya, T Tatar-Kis, T Mato, et al.  \"Vet Immunol Immunopathol.\"  158, \"Onset and long-term duration of immunity provided by a single vaccination with a turkey herpesvirus vector ND vaccine in commercial layers.\" 105 (2014)","DOI":"10.1016\/j.vetimm.2013.11.008"},{"key":"23","doi-asserted-by":"crossref","unstructured":"KJ Livak  and TD Schmittgen  \"Methods.\"  25, \"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.\" 402 (2001)","DOI":"10.1006\/meth.2001.1262"},{"key":"27","doi-asserted-by":"crossref","unstructured":"J Gelb, DJ Jackwood, EM Brannick, et al.  \"Avian Dis.\"  60, \"Efficacy of recombinant HVT-IBD vaccines administered to broiler chicks from a single breeder flock at 30 and 60 weeks of age.\" 603 (2016)","DOI":"10.1637\/11344-120815-Reg.1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"V Palya, I Kiss, T Tatar-Kis, et al.  \"Avian Dis.\"  56, \"Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.\" 282 (2012)","DOI":"10.1637\/9935-091511-Reg.1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"JS Guy, HJ Barnes, L Smith,  \"Avian Dis.\"  35, \"Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage.\" 348 (1991)","DOI":"10.2307\/1591188"},{"key":"16","doi-asserted-by":"crossref","unstructured":"I Oldoni, A Rodr\u00edguez-Avila, SM Riblet, et al.  \"Avian Pathol.\"  38, \"Pathogenicity and growth characteristics of selected infectious laryngotracheitis virus strains from the United States.\" 47 (2009)","DOI":"10.1080\/03079450802632031"},{"key":"10","doi-asserted-by":"crossref","unstructured":"M Garc\u00eda  and G Zavala  \"Avian Dis.\"  63, \"Commercial vaccines and vaccination strategies against infectious laryngotracheitis: what we have learned and knowledge gaps that remain.\" 325 (2019)","DOI":"10.1637\/11967-090218-Review.1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"M Garc\u00eda, J Volkening, S Riblet, et al.  \"Virology.\"  440, \"Genomic sequence analysis of the United States infectious laryngotracheitis vaccine strains chicken embryo origin (CEO) and tissue culture origin (TCO).\" 64 (2013)","DOI":"10.1016\/j.virol.2013.02.007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"M Esaki, L Noland, T Eddins, et al.  \"Avian Dis.\"  57, \"Safety and efficacy of a turkey herpesvirus vector laryngotracheitis vaccine for chickens.\" 192 (2013)","DOI":"10.1637\/10383-092412-Reg.1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"D Maekawa, SM Riblet, L Newman, et al.  \"Avian Pathol.\"  48, \"Evaluation of vaccination against infectious laryngotracheitis (ILT) with recombinant herpesvirus of turkey (rHVT-LT) and chicken embryo origin (CEO) vaccines applied alone or in combination.\" 573 (2019)","DOI":"10.1080\/03079457.2019.1644449"},{"key":"1","doi-asserted-by":"crossref","unstructured":"M Garc\u00eda  and S Spatz  \"Diseases of poultry.\"  \"Infectious laryngotracheitis.\" 189 (2020)","DOI":"10.1002\/9781119371199.ch5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"TJ Bagust, RC Jones, JS Guy,  \"Rev Sci Tech.\"  19, \"Avian infectious laryngotracheitis.\" 483 (2000)","DOI":"10.20506\/rst.19.2.1229"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Y Samberg, E Cuperstein, U Benheim, et al.  \"Avian Dis.\"  15, \"The development of a vaccine against avian infectious laryngotracheitis. Immunizations of chickens with modified laryngotracheitis vaccine in the drinking water.\" 413 (1971)","DOI":"10.2307\/1588714"},{"key":"4","doi-asserted-by":"crossref","unstructured":"EF Gelenczei  and EW Marty  \"Avian Dis.\"  8, \"Studies on a tissue culture modified infectious laryngotracheitis virus.\" 105 (1964)","DOI":"10.2307\/1587827"},{"key":"5","doi-asserted-by":"crossref","unstructured":"A Vagnozzi, G Zavala, S Riblet, et al.  \"Avian Pathol.\"  41, \"Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens.\" 21 (2012)","DOI":"10.1080\/03079457.2011.631983"},{"key":"8","doi-asserted-by":"crossref","unstructured":"A Rodr\u00edguez-Avila, I Oldoni, SM Riblet, et al.  \"Avian Dis.\"  51, \"Replication and transmission of live-attenuated infectious laryngotracheitis virus (ILTV) vaccines.\" 905 (2007)","DOI":"10.1637\/8011-041907-REGR.1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"W Fuchs, J Veits, D Helferich, et al.  \"Vet Res.\"  38, \"Molecular biology of avian infectious laryngotracheitis virus.\" 261 (2007)","DOI":"10.1051\/vetres:200657"},{"key":"13","doi-asserted-by":"crossref","unstructured":"J Veits, TC Mettenleiter, W Fuchs,  \"J Gen Virol.\"  84, \"Five unique open reading frames of infectious laryngotracheitis virus are expressed during infection but are dispensable for virus replication in cell culture.\" 1415 (2003)","DOI":"10.1099\/vir.0.18926-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"M Garcia, SJ Spatz, Y Cheng, et al.  \"J Gen Virol.\"  97, \"Attenuation and protection efficacy of ORF C gene-deleted recombinant of infectious laryngotracheitis virus.\" 2352 (2016)","DOI":"10.1099\/jgv.0.000521"},{"key":"15","doi-asserted-by":"crossref","unstructured":"GH Schneiders, SM Riblet, M Garc\u00eda,  \"Avian Dis.\"  62, \"Attenuation and protection efficacy of a recombinant infectious laryngotracheitis virus (ILTV) depleted of open reading frame C (\u0394ORFC) when delivered\" 143 (2018)","DOI":"10.1637\/11585-010917-RegR"},{"key":"17","doi-asserted-by":"crossref","unstructured":"A Rodr\u00edguez-Avila, I Oldoni, S Riblet, et al.  \"Avian Pathol.\"  37, \"Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United States.\" 287 (2008)","DOI":"10.1080\/03079450802043742"},{"key":"18","doi-asserted-by":"crossref","unstructured":"L Reed  and H Muench  \"Am J Trop Med Hyg.\"  27, \"A simple method of estimating fifty percent end-points.\" 493 (1938)","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"19","doi-asserted-by":"crossref","unstructured":"CJ Williams  and BA Hopkins  \"Poult Sci.\"  90, \"Field evaluation of the accuracy of vaccine deposition by two different available in ovo injection systems.\" 223 (2011)","DOI":"10.3382\/ps.2010-00759"},{"key":"20","doi-asserted-by":"crossref","unstructured":"D Maekawa, G Beltr\u00e1n, SM Riblet, et al.  \"Avian Dis.\"  63, \"Protection efficacy of a recombinant herpesvirus of turkey vaccine against infectious laryngotracheitis virus administered in ovo to broilers at three standardized doses.\" 351 (2019)","DOI":"10.1637\/12029-011119-Reg.1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"AF Islam, B Harrison, BF Cheetham, et al.  \"J Virol Methods.\"  119, \"Differential amplification and quantitation of Marek's disease viruses using real-time polymerase chain reaction.\" 103 (2004)","DOI":"10.1016\/S0166-0934(04)00084-9"},{"key":"22","doi-asserted-by":"crossref","unstructured":"A Vagnozzi, S Riblet, G Zavala, et al.  \"Avian Dis.\"  56, \"Optimization of a duplex real-time PCR method for relative quantitation of infectious laryngotracheitis virus (ILTV).\" 406 (2012)","DOI":"10.1637\/9883-081111-ResNote.1"},{"key":"24","unstructured":"\"GraphPad Prism Version 8. [Computer software].\"  (2018)"},{"key":"25","doi-asserted-by":"crossref","unstructured":"JJ Giambrone  and J Closser  \"Poult Sci.\"  68, \"Efficacy of simultaneous administration of Marek's disease and viral tenosynovitis vaccines to day-old broiler chickens.\" 1213 (1989)","DOI":"10.3382\/ps.0681213"},{"key":"26","doi-asserted-by":"crossref","unstructured":"HL Ferreira, AM Reilley, D Goldenberg, et al.  \"Vaccine.\"  38, \"Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens.\" 5507","DOI":"10.1016\/j.vaccine.2020.06.004"}],"container-title":["Avian Diseases"],"original-title":[],"link":[{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-65\/issue-3\/aviandiseases-D-20-00050\/A-Cell-Line-Adapted-Infectious-Laryngotracheitis-Virus-Strain-B%CE%94ORFC-for\/10.1637\/aviandiseases-D-20-00050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:38:34Z","timestamp":1793435914000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/avian-diseases\/volume-65\/issue-3\/aviandiseases-D-20-00050\/A-Cell-Line-Adapted-Infectious-Laryngotracheitis-Virus-Strain-B%CE%94ORFC-for\/10.1637\/aviandiseases-D-20-00050.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9,1]]}},"URL":"https:\/\/doi.org\/10.1637\/aviandiseases-d-20-00050","relation":{},"ISSN":["0005-2086","1938-4351"],"issn-type":[{"value":"0005-2086","type":"print"},{"value":"1938-4351","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]}}}